Disease groups
1,086 disease groups whose chain reached a human disease, by OMIA group number.
| OMIA group | Name | Species | The chain reached | Best score |
|---|---|---|---|---|
| 979 | Talpid-3 | 1 | Target evidence | 56.9 |
| 985 | Teat / nipple, number | 7 | Human disease | 15.0 |
| 991 | Androgen insensitivity syndrome (AIS) | 7 | Human disease | 20.0 |
| 994 | Tetralogy of Fallot | 6 | Human disease | 15.0 |
| 1000 | Thrombasthenia | 3 | Drug | 89.5 |
| 1001 | Thrombocytopenia | 6 | Human disease | 40.0 |
| 1002 | Thrombocytopathy | 1 | Human disease | 9.0 |
| 1005 | Thyroiditis | 2 | Human disease | 34.5 |
| 1009 | Hemimelia, tibial | 2 | Target evidence | 33.9 |
| 1013 | Torticollis | 3 | Human disease | 15.0 |
| 1016 | Tremor | 6 | Human disease | 15.0 |
| 1021 | Tricuspid stenosis | 1 | Human disease | 6.5 |
| 1033 | Urolithiasis | 30 | Target evidence | 62.4 |
| 1040 | Ventricular arrhythmias and sudden death | 1 | Human gene | 29.0 |
| 1041 | Ventricular septal defect | 12 | Human disease | 15.0 |
| 1046 | Vertebral anomalies | 6 | Human disease | 15.0 |
| 1054 | Vitamin-K-dependent blood coagulation factors deficiency | 3 | Drug | 64.3 |
| 1055 | Vitiligo | 8 | Human disease | 15.0 |
| 1056 | Von Willebrand disease, generic | 6 | Drug | 65.4 |
| 1057 | Von Willebrand disease I | 2 | Drug | 62.1 |
| 1058 | Von Willebrand disease III | 4 | Drug | 65.4 |
| 1059 | Waardenburg syndrome, generic | 2 | Human disease | 12.0 |
| 1071 | Wilson disease | 7 | Target evidence | 95.2 |
| 1081 | Muscular dystrophy, Duchenne type | 4 | Drug | 92.4 |
| 1090 | Fatty metamorphosis of viscera | 5 | Human disease | 15.0 |
| 1097 | Necrotising encephalopathy, subacute, of Leigh | 3 | Target evidence | 64.0 |
| 1100 | Polymicrogyria | 1 | Human disease | 6.5 |
| 1102 | Situs inversus | 3 | Human disease | 15.0 |
| 1104 | Thrombocytopenic purpura, autoimmune | 2 | Human disease | 37.0 |
| 1106 | Axonopathy | 1 | Target evidence | 58.7 |
| 1107 | Hymen, imperforate | 2 | Human disease | 12.0 |
| 1109 | Mycosis fungoides | 3 | Human disease | 40.0 |
| 1112 | Nephritis, X-linked | 1 | Drug | 65.9 |
| 1113 | Nephroma | 1 | Human disease | 6.5 |
| 1114 | Nephritis, autosomal dominant | 1 | Human disease | 9.0 |
| 1127 | Otocephaly, generic | 2 | Human disease | 12.0 |
| 1132 | Spondylosis deformans | 4 | Human disease | 15.0 |
| 1134 | Masticatory muscle myositis | 1 | Human disease | 9.0 |
| 1135 | Renal dysplasia | 5 | Target evidence | 64.4 |
| 1138 | Hypocatalasia | 2 | Target evidence | 56.4 |
| 1139 | Glycogen storage disease V | 2 | Target evidence | 81.7 |
| 1141 | Tyrosinemia, type II | 1 | Human disease | 9.0 |
| 1142 | Wilms tumour | 5 | Human disease | 15.0 |
| 1147 | Papillomatosis, cutaneous | 3 | Human disease | 15.0 |
| 1150 | Neuropathy, peripheral | 3 | Human disease | 32.0 |
| 1156 | Spongiform myelopathy | 1 | Human disease | 24.0 |
| 1158 | Polysaccharide storage myopathy/PSSM1/Exertional rhabdomyolysis | 4 | Human disease | 15.0 |
| 1160 | Hyperlipidaemia | 7 | Human disease | 15.0 |
| 1161 | Self-mutilation syndrome | 1 | Human disease | 34.0 |
| 1165 | Motor neuron disease | 2 | Human disease | 12.0 |